Evidence map›Paper›PMID 29464074›Full record

ArticleOncotarget2018

A lethal synergy induced by phellinus linteus and camptothecin11 in colon cancer cells.

Tianqi Yu, Suthakar Ganapathy, Ling Shen, Bo Peng, Sung-Hoon Kim, Alexandros Makriyannis, Changyan Chen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. American journal of cancer research · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tianqi YuThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Suthakar GanapathyThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Ling ShenThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Bo PengThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Sung-Hoon KimCancer Molecular Targeted Herbal Research Center, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Alexandros MakriyannisThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Changyan ChenThe Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Northeastern University · USKyung Hee University · KR

Funding

MOLECULAR BASIS OF CANNABINOID ACITIVITYR37DA003801 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI MAKRIYANNIS, ALEXANDROS · 1997 to 2006
$3.7M
MOLECULAR BASIS OF CANNABINOID ACTIVITYR01DA003801 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI MAKRIYANNIS, ALEXANDROS · 1985 to 2017
$2.5M
Study of Ras-Mediated ApoptosisR01CA100498 · NCI · NORTHEASTERN UNIVERSITY · PI CHEN, CHANGYAN · 2004 to 2017
$2.5M
Study of Anti-Survival signals in NF1R01CA153354 · NCI · NORTHEASTERN UNIVERSITY · PI CHEN, CHANGYAN · 2012 to 2017
$1.6M
NCI NIH HHS R01 CA100498NCI NIH HHS R01 CA153354NIDA NIH HHS R01 DA003801NIDA NIH HHS R37 DA003801
6 · The paper itself

Abstract

Side effects of anti-cancer drugs are always challenging for effective cancer treatments. The polysaccharides extracted from

Indexed as

Chk1CPT11cyclin EPLGLS phase

Identifiers

PMID29464074
PMCPMC5814214
OpenAlexW2782047020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.